Company Search:
Advanced Search
Sponsored Links
Abeona Therapeutics Inc Company Snapshot
Abeona Therapeutics Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abeona Therapeutics Inc with three other companies in this sector in the United States: Cyclacel Pharmaceuticals, Inc. (2016 sales of $843,000.00 of which 100% was Pharmaceutical Products), Pulmatrix Inc ($835,000.00 ), and Ibio, Incorporation ($948,000.00 ).

Sales Analysis. During the year ended December of 2016, sales at Abeona Therapeutics Inc were $889,000.00 . This is a decrease of 14.5% versus 2015, when the company's sales were $1.04 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Abeona Therapeutics Inc
  Stock Performance Chart for Abeona Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 15.70
(Figures in U.S. Dollars)
1 Week 0.3%   13 Weeks -4.8%  
4 Weeks -2.5%   52 Weeks 196.2%  
Abeona Therapeutics Inc Key Data:
  Ticker: ABEO Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 889,000
(Year Ending Jan 2017).
Employees: 6
  Currency: U.S. Dollars Market Cap: 734,371,535
  Fiscal Yr Ends: December Shares Outstanding: 46,775,257
  Share Type: Common Closely Held Shares: 16,716,740
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.